Viewing Study NCT05267366


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2025-12-26 @ 8:25 AM
Study NCT ID: NCT05267366
Status: UNKNOWN
Last Update Posted: 2023-03-29
First Post: 2022-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy Combines With Bevacizumab and PD-1 Inhibitor in Non-squamous NSCLC
Sponsor: Qingdao Central Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module